Endothelin receptor blockade and exacerbation of heart failure.
Szokodi
István
I
Piuhola
Jarkko
J
Ruskoaho
Heikki
H
D000818:Animals; D000077300:Bosentan; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D065128:Endothelin Receptor Antagonists; D016232:Endothelins / Q000502:physiology; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D010666:Phenylpropionates / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D051381:Rats; D044022:Receptor, Endothelin A; D013449:Sulfonamides / Q000009:adverse effects / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects*
D065128:Endothelin Receptor Antagonists; D016232:Endothelins; D010666:Phenylpropionates; D011743:Pyrimidines; D044022:Receptor, Endothelin A; D013449:Sulfonamides; C107831:darusentan; D000077300:Bosentan